[1]
2026. CLINICAL PROFILE AND TREATMENT RESULTS OF PATIENTS RECEIVING BPALM REGIMEN FOR DRUG-RESISTANT TUBERCULOSIS AT A TERTIARY CARE TEACHING HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. Asian Journal of Medical Research and Health Sciences. 4, 2 (Jun. 2026), 1084–1089.